Shahbaz Qureshi
Overview
Explore the profile of Shahbaz Qureshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malik A, Malik M, Javaid S, Qureshi S, Nadir A
Int J Obes (Lond)
. 2024 Oct;
49(1):54-62.
PMID: 39397157
Bariatric surgery is recommended for patients with unhealthy weight. Our study aim to compare and rank different bariatric surgical approaches in reducing weight parameters. We searched MEDLINE, Cochrane CENTRAL, Scopus,...
2.
Malik A, Nadir A, Malik M, Qureshi S, Adler D
Am J Ther
. 2024 Sep;
31(5):e560-e564.
PMID: 39292835
No abstract available.
3.
Malik A, Javaid S, Malik M, Qureshi S
Ann Hepatol
. 2024 Aug;
29(6):101544.
PMID: 39214253
Introduction And Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) formerly known as Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease. Identifying MASLD risk factors could help early intervention...
4.
Khan S, Malik A, Qureshi S, Cohen B, Nadir A
Am J Case Rep
. 2024 Jul;
25:e943787.
PMID: 39014872
BACKGROUND Malignant peritoneal mesothelioma (MPM) is a rare, lethal tumor of serous membranes. The most common factor reported in association with MPM is asbestos exposure, while viral infections, genetic predisposition,...
5.
Malik A, Ali F, Malik M, Qureshi S
Gastroenterology Res
. 2024 Jul;
17(3):133-145.
PMID: 38993548
Background: Gastric adenocarcinoma (GAC) is a deadly tumor. Postoperative complications, including infections, worsen its prognosis and may affect overall survival. Little is known about perioperative complications as well as modifiable...
6.
Malik A, Qureshi S, Nadir A, Malik M, Adler D
Indian J Gastroenterol
. 2024 Apr;
43(4):740-747.
PMID: 38564157
Methods: We searched Cochrane CENTRAL, PubMed, Web of Science, SCOPUS and Embase for related clinical trials about patients suffering from achalasia. The quality appraisal and assessment of risk of bias...
7.
Malik A, Nadir A, Javaid S, Qureshi S, Adler D
J Gastrointestin Liver Dis
. 2024 Mar;
33(1):137-138.
PMID: 38554430
No abstract available.
8.
Malik A, Malik M, Qureshi S
Can Liver J
. 2024 Mar;
7(1):40-53.
PMID: 38505782
Background: Fatty liver disease comprises a wide range of related liver disorders affecting mainly people who drink no or minimal amounts of alcohol. Silymarin is a member of the family...
9.
Malik A, Malik M, Qureshi S, Nadir A
Ann Hepatol
. 2024 Mar;
29(4):101495.
PMID: 38460713
Introduction And Objectives: Hepatorenal syndrome (HRS) is a serious complication of cirrhosis treated with various medications. We aim to evaluate terlipressin and albumin's effectiveness and safety compared to albumin and...
10.
Khalid S, Maqbool S, Raza N, Mukhtar T, Ikram A, Qureshi S
J Coll Physicians Surg Pak
. 2013 Apr;
23(4):293-4.
PMID: 23552544
Hematohidrosis is a rare condition of excreting blood in sweat, tears or any other part of the body, with varied underlying etiologies and variable success to different available treatment modalities....